Indeed, inhibition of Cbl by the chemical inhibitor hydrocotarnine increased IL-18 secretion and protected from colitis in DSS-treated mice, suggesting that Cbl restrains gut inflammation by limiting inflammasome activation [70]. This evidence concerns the gene CBL and colitis.